Vor Ort
Merkzettel Warenkorb
  • Produktbild: Risk Management in Blood Transfusion: The Virtue of Reality
  • Produktbild: Risk Management in Blood Transfusion: The Virtue of Reality
Band 34 - 12%

Risk Management in Blood Transfusion: The Virtue of Reality Proceedings of the Twenty-Third International Symposium on Blood Transfusion, Groningen 1998, organized by the Blood Bank Noord Nederland

Aus der Reihe Developments in Hematology and Immunology
12% sparen

187,99 € UVP 213,99 €

inkl. gesetzl. MwSt., Versandkostenfrei

Beschreibung

Produktdetails

Einband

Taschenbuch

Erscheinungsdatum

07.12.2010

Abbildungen

XII, 236 p.

Herausgeber

C.Th. Smit Sibinga + weitere

Verlag

Springer Us

Seitenzahl

236

Maße (L/B/H)

23,5/15,5/1,4 cm

Gewicht

388 g

Auflage

1999

Sprache

Englisch

ISBN

978-1-4419-4822-9

Beschreibung

Produktdetails

Einband

Taschenbuch

Erscheinungsdatum

07.12.2010

Abbildungen

XII, 236 p.

Herausgeber

Verlag

Springer Us

Seitenzahl

236

Maße (L/B/H)

23,5/15,5/1,4 cm

Gewicht

388 g

Auflage

1999

Sprache

Englisch

ISBN

978-1-4419-4822-9

Herstelleradresse

Springer-Verlag KG
Sachsenplatz 4-6
1201 Wien
AT

Email: GPSR Kontakt

Noch keine Bewertungen vorhanden

Verfassen Sie die erste Bewertung zu diesem Artikel

Helfen Sie anderen Kundinnen und Kunden durch Ihre Meinung.

Kundinnen und Kunden meinen

Bewertungen (0)
  • Produktbild: Risk Management in Blood Transfusion: The Virtue of Reality
  • Produktbild: Risk Management in Blood Transfusion: The Virtue of Reality
  • I. Perception of Risk.- Does Perceived Risk Withhold People from Donating Blood?.- Managing Risks from an Insurer’s Perspective.- Bad Blood or the Elixir of Life? Perceived Risk of Blood Transfusions.- The Role of Cost-Effectiveness Analysis in Defining Transfusion Medicine Policy.- II. Management of Infection Defined Risks.- Risks of Transfusion-Transmitted Infection: A Comparative Analysis of Then and Now.- Prevention of Transfusion Transmissible Infections: The Impact of the Recent Past on Current Decision Making.- Management of Infection-Defined Risks.- Closing the Window of Early HIV Infection by Incorporation of HIV p24 Ag Detection.- GAT Testing: Added Value?.- III. Management of Immune Defined Risks.- The Role of T and B Cells in Transfusion-Related Immune Reactions: Cytokines and the Removal of Apoptotic Material.- Involvement of B-cells in Peripheral Scrapie Pathogenesis.- Alternative Approaches to Prevention of Alloimmunisation: A Virtue of Reality?.- Transfusion-Associated Immunodulation in Cancer Recurrence and Postoperative Infection: Meta-Analyses of Randomised Controlled Trials.- Does General Leukodepletion Provide Any Better Outcome?.- IV. Risk Management in Clinical Practice: Optimal vs Maximal.- Haemovigilance: An Approach to Risk Management and Control.- Evidence-Based Transfusion Medicine: A Fundamental Part of Risk Management.- Safety and Supply Issues from Consumers Point of View.- The Value of Education to Improve Perception, Acceptance and Communication of Transfusion-Related Risk.- This is the Bloody Limit.- The Virtue of Reality: Global Strategies in the Management of Transfusion-Related Risks.